Pharmacological inhibition from the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged being a promising technique for most cancers therapy that exploits artificial lethal interactions with proteins associated with DNA damage maintenance, overcomes resistance to other therapies and enhances antitumo... https://augustinee333pco6.mdkblog.com/profile